Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study

被引:0
|
作者
Georges Bucyibaruta
Marta Blangiardo
Garyfallos Konstantinoudis
机构
[1] Imperial College London,Department of Epidemiology and Biostatistics, MRC Centre for Environment and Health, School of Public Health
来源
European Journal of Epidemiology | 2022年 / 37卷
关键词
COVID-19; Spatial modelling; Vaccine inequalities; Community-level characteristics;
D O I
暂无
中图分类号
学科分类号
摘要
One year after the start of the COVID-19 vaccination programme in England, more than 43 million people older than 12 years old had received at least a first dose. Nevertheless, geographical differences persist, and vaccine hesitancy is still a major public health concern; understanding its determinants is crucial to managing the COVID-19 pandemic and preparing for future ones. In this cross-sectional population-based study we used cumulative data on the first dose of vaccine received by 01-01-2022 at Middle Super Output Area level in England. We used Bayesian hierarchical spatial models and investigated if the geographical differences in vaccination uptake can be explained by a range of community-level characteristics covering socio-demographics, political view, COVID-19 health risk awareness and targeting of high risk groups and accessibility. Deprivation is the covariate most strongly associated with vaccine uptake (Odds Ratio 0.55, 95%CI 0.54-0.57; most versus least deprived areas). The most ethnically diverse areas have a 38% (95%CI 36-40%) lower odds of vaccine uptake compared with those least diverse. Areas with the highest proportion of population between 12 and 24 years old had lower odds of vaccination (0.87, 95%CI 0.85-0.89). Finally increase in vaccine accessibility is associated with COVID-19 vaccine coverage (OR 1.07, 95%CI 1.03-1.12). Our results suggest that one year after the start of the vaccination programme, there is still evidence of inequalities in uptake, affecting particularly minorities and marginalised groups. Strategies including prioritising active outreach across communities and removing practical barriers and factors that make vaccines less accessible are needed to level up the differences.
引用
收藏
页码:1071 / 1081
页数:10
相关论文
共 50 条
  • [1] Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study
    Bucyibaruta, Georges
    Blangiardo, Marta
    Konstantinoudis, Garyfallos
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2022, 37 (10) : 1071 - 1081
  • [2] COVID-19 Parental Vaccine Hesitancy in Romania: Nationwide Cross-Sectional Study
    Manolescu, Loredana Sabina Cornelia
    Zaharia, Corneliu Nicolae
    Dumitrescu, Anca Irina
    Prasacu, Irina
    Radu, Mihaela Corina
    Boeru, Adrian Calin
    Boidache, Liliana
    Nita, Irina
    Necsulescu, Andrei
    Medar, Cosmin
    Cristache, Corina Marilena
    Chivu, Razvan Daniel
    VACCINES, 2022, 10 (04)
  • [3] COVID-19 vaccine hesitancy in Egypt: a cross-sectional study
    Shawki, May Ahmed
    Kamel, Ahmed
    Gamal, Shaza
    Abbassi, Maggie Magdy
    Farid, Samar Farghali
    Sabry, Nirmeen Ahmed
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (09): : 1188 - +
  • [4] COVID-19 Vaccine Hesitancy in Pregnancy: A Cross-Sectional Study
    Ercan, Aysegul
    Senol, Ebru
    Firat, Aysun
    JOURNAL OF CLINICAL OBSTETRICS AND GYNECOLOGY, 2022, 32 (01): : 7 - 12
  • [5] Community Level Correlates of COVID-19 Booster Vaccine Hesitancy in the United States: A Cross-Sectional Analysis
    Krasner, Henry
    Harmon, Nicolette
    Martin, Jeffrey
    Olaco, Crysty-Ann
    Netski, Dale M.
    Batra, Kavita
    VACCINES, 2024, 12 (02)
  • [6] Predictors of COVID-19 vaccine hesitancy in Chad: A cross-sectional study
    Takoudjou Dzomo, Guy Rodrigue
    Mbario, Edmond
    Djarma, Oumaima
    Soumbatingar, Ndilbe
    Madengar, Mouassede
    Djimera, Nadia
    Djindimadje, Allarangue
    Nguemadjita, Christian
    Nassaringar, Guirimadje
    Bernales, Margarita
    Nangerngar, Togoumbaye
    Naissem, Denise
    Paningar, Ephrem
    Gomez-Virseda, Carlos
    Lopez Barreda, Rodrigo
    Robbins, Ian
    Cournil, Amandine
    Visier, Laurent
    Tuaillon, Edouard
    Mennechet, Franck J. D.
    FRONTIERS IN PUBLIC HEALTH, 2023, 10
  • [7] COVID-19 vaccine hesitancy in the UK: a longitudinal household cross-sectional study
    Kausik Chaudhuri
    Anindita Chakrabarti
    Joht Singh Chandan
    Siddhartha Bandyopadhyay
    BMC Public Health, 22
  • [8] Factors associated with COVID-19 booster vaccine hesitancy: a nationwide, cross-sectional survey in Japan
    Takamatsu, A.
    Honda, H.
    Miwa, T.
    Tabuchi, T.
    Taniguchi, K.
    Shibuya, K.
    Tokuda, Y.
    PUBLIC HEALTH, 2023, 223 : 72 - 79
  • [9] COVID-19 vaccine hesitancy in the UK: a longitudinal household cross-sectional study
    Chaudhuri, Kausik
    Chakrabarti, Anindita
    Chandan, Joht Singh
    Bandyopadhyay, Siddhartha
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [10] COVID-19 vaccine hesitancy in Ethiopia in 2021: a multicenter cross-sectional study
    Erega, Besfat Berihun
    Ferede, Wassie Yazie
    Sisay, Fillorenes Ayalew
    Tiruneh, Gebrehiwot Ayalew
    Ayalew, Abeba Belay
    Malka, Erean shigign
    Tassew, Habtamu Abie
    Alemu, Asrat
    IJID REGIONS, 2023, 6 : 120 - 124